Locations:
Search IconSearch
February 20, 2026/Innovations

Cleveland Clinic Innovations 2025 Year in Review: Built on Legacy, Wired for the Future

In 2025, we reimagined what it means to partner with Cleveland Clinic Innovations and expanded the ways we bring innovations to patients at scale. In doing so, we saw 58 new license agreements and 207 new invention disclosures. We announced a collaboration with Khosla Ventures, one of Silicon Valley’s leading investors in healthcare commercialization and technology—an example of how we’re strategically connecting outside innovation to our world-class ecosystem of research, discovery and clinical talent.

Woman working in a laboratory setting

Innovation rarely happens in a straight line, and at Cleveland Clinic Innovations (CCI), our approach is ever evolving.

Our 2025 Year in Review highlights how far we’ve come in building systems and processes designed for the future of healthcare innovation. It showcases new, effective pathways we’ve created for partnering with us – accelerating the journey of new inventions to patients while reducing risk along the way.

Read our 2025 Year in Review

As we look toward opportunities in 2026, we’re proud to reflect on a year marked by momentum and measurable impact:

In 2025, we delivered:

  • 207 invention disclosures
  • 58 license agreements
  • 207 new inventors
  • $97 million+ in capital raised

We advanced deployment of clinically validated artificial intelligence in sepsis care, oncology, neurology and other critical specialties to improve patient outcomes at scale.

We forged new external partnerships, including one with Khosla Ventures, providing pipelines to emerging technologies in artificial intelligence, digital health and next-generation therapeutics.

Our world-class ecosystem of research, discovery and unmatched clinical talent elevates our credibility as a commercialization partner of choice. Today, our 37 portfolio companies are progressing through key regulatory milestones and advancing through funding rounds. 2025 showed what’s possible when clinical expertise, data and the right partnerships come together. Stay connected with us as we continue to transform healthcare through innovation and technological advancement. If you are exploring licensing, co-development, venture collaboration or strategic investment opportunities, our team is ready to help you discover what’s possible.

Latest from the Newsroom

Logos of Cleveland Clinic and the Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic

Leading Researchers and Advocates Honored by Maria Shriver and The Women’s Alzheimer’s Movement at Cleveland Clinic

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights